Shares of Ocugen Inc. OCGN, -6.47% shed 6.47% to $1.59 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -2.50% falling 2.50% to 3,759.69 and Dow Jones Industrial Average DJIA, -1.55% falling 1.55% to 32,147.76. This was the stock’s third consecutive day of losses. Ocugen Inc. closed $16.06 short of its 52-week high ($17.65), which the company reached on November 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM, -3.89% fell 3.89% to $0.84, Ocular Therapeutix Inc. OCUL, -4.31% fell 4.31% to $3.55, and Kodiak Sciences Inc. KOD, -2.26% fell 2.26% to $6.93. Trading volume (5.7 M) eclipsed its 50-day average volume of 5.0 M.